New drug duo aims to ease strain on failing hearts and lungs
Disease control
Not yet recruiting
This study is testing if adding the drug macitentan to a standard heart failure drug (dapagliflozin) works better for patients who have a specific type of heart failure combined with high blood pressure in the lungs. About 64 participants will be randomly assigned to take either …
Phase: PHASE4 • Sponsor: Gachon University Gil Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC